Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: MD Anderson


More study details and costs warranted in release on immunotherapy for advanced bladder cancer

1 4/25/2016

Harms, costs and clear benefits omitted from release on anal cancer drug trial


More context would be helpful on kidney cancer “breakthrough”


Beta-blockers “prolong survival” in ovarian cancer? Not so fast